- জেনেরিক নাম
- Palonosetron
- শক্তি
- 500 mcg
- ডোজ ফর্ম
- Capsule
- প্রস্তুতকারক
- Renata PLC.
Vomiren Soft Gel Capsule Capsule
Vomiren Soft Gel Capsule 500 mcg সম্পর্কে
Vomiren Soft Gel Capsule হলো Palonosetron-এর একটি ব্র্যান্ড, শক্তি ৫০০ mcg, ক্যাপসুল আকারে। Palonosetron-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। এটি তৈরি করে Renata PLC। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।
Palonosetron-এর ১৬টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত।
Vomiren Soft Gel Capsule 500 mcg কী?
Vomiren Soft Gel Capsule contains palonosetron 500 mcg and belongs to a group of medicines called anti-emetics. It works by blocking certain receptors involved in the vomiting reflex. It is used for acute and delayed nausea and vomiting, including nausea and vomiting caused by chemotherapy or radiotherapy, and for uncontrolled nausea and vomiting. Because it is a prescription medicine, the doctor decides whether it is suitable and how it should be taken. Do not start, stop or change it without medical advice.
Vomiren Soft Gel Capsule-এর ব্যবহার
Vomiren Soft Gel Capsule is used to treat acute and delayed nausea and vomiting. It is also used for uncontrolled nausea and vomiting and for nausea and vomiting caused by chemotherapy or radiotherapy. It is an anti-emetic medicine, meaning it acts against nausea and vomiting. Only a doctor can decide if it is appropriate for a particular person and situation.
Vomiren Soft Gel Capsule কীভাবে ব্যবহার করবেন
Take Vomiren Soft Gel Capsule exactly as the doctor tells you. The doctor decides the dose, when to take it and how long the course should last, so follow the prescription and the pharmacist's instructions. Swallow the capsule as directed. If you are unsure how or when to take it, ask your doctor or pharmacist. Do not change the dose or stop it on your own.
Vomiren Soft Gel Capsule-এর পার্শ্বপ্রতিক্রিয়া
The most common side effects are headache and constipation. Tell your doctor if these bother you or do not settle. Ask your doctor or pharmacist about anything unusual you notice after taking Vomiren Soft Gel Capsule, and seek medical help promptly if you have a severe reaction or any symptom that worries you. Do not self-treat side effects without advice.
সতর্কতা ও নিরাপত্তা
Vomiren Soft Gel Capsule should not be used by anyone who is hypersensitive to palonosetron or to any of its ingredients. It is classified as pregnancy category B, and it is not known whether palonosetron passes into breast milk. Tell the doctor if you are pregnant, planning a pregnancy or breastfeeding, and about any other medicines you take, including those bought without a prescription. Ask the doctor first if you have any health concerns or allergies.
সাধারণ প্রশ্ন
What is Vomiren Soft Gel Capsule used for and what kind of medicine is it?
It is an anti-emetic medicine containing palonosetron. It is used for acute and delayed nausea and vomiting, uncontrolled nausea and vomiting, and nausea and vomiting caused by chemotherapy or radiotherapy. The doctor decides if it is suitable for you.
What side effects should I watch for, and when should I call the doctor?
Headache and constipation are the most common side effects. Call your doctor if these are troublesome or do not settle, or if you notice any severe or worrying reaction. Do not treat side effects yourself without asking a doctor or pharmacist first.
How should I store Vomiren Soft Gel Capsule?
Keep it in a cool, dry place away from light. Store it out of the reach of children, and do not use it after the expiry date. If you are unsure about storage, ask your pharmacist.
Can I take Vomiren Soft Gel Capsule without a prescription?
No. It is an anti-emetic medicine that should be used only when a doctor has prescribed it. The doctor decides the dose and course. Do not start, stop or change it on your own, and tell the doctor about other medicines you take.
নির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Palonosetron indicated in-- Acute and delayed nausea and vomiting
- Uncontrolled nausea and vomiting
- Chemotherapy-induced nausea and vomiting (CINV): Acute CINV resulting in on the day of treatment with certain types of chemotherapy
- Delayed CINV resulting in on days later with certain types of chemotherapy ... Read more
- Acute and delayed nausea and vomiting
- Uncontrolled nausea and vomiting
- Chemotherapy-induced nausea and vomiting (CINV): Acute CINV resulting in on the day of treatment with certain types of chemotherapy
- Delayed CINV resulting in on days later with certain types of chemotherapy
- Radiotherapy-induced nausea and vomiting (RINV)
- Post-operative & Post-discharge nausea and vomiting (PONV & PDNV).
ফার্মাকোলজি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Palonosetron is a 5-HT3 receptor antagonist with a strong binding affinity for this receptor and little or no affinity for other receptors. It is thought that chemotherapeutic agents produce nausea and vomiting by releasing serotonin from the enterochromaffin cells of the small intestine and that the released serotonin then activates 5-HT3 receptors that are located on the nerve terminals of the vagus in the periphery and centrally in the chemoreceptor trigger zone of the area postrema, to initiate the vomiting reflex. Postoperative nausea and vomiting is influenced by multiple patient, surgical and anesthesia related factorcs and is triggered by release of 5-HT3 in a cascade of neuronal event involving both the central nervous system and the gastrointestinal tract. The 5-HT3 receptor has been demonstrated to selectively participate in the emetic response. Palonosetron works by blocking the actions of Serotonin, associated with nausea and vomiting, at 5-HTs receptor. It is likely that Palonosetron works in the small intestine but it may also work in the brain.Pharmacokinetics: Palonosetron exhibits linear dose-proportional pharmacokinetics over the doserange 1-90 pg/kg in healthy subjects and in patients with cancer. In cancer patients receiving single intravenous doses of Palonosetron in this dose range, the mean maximum plasma concentration (Cmax) ranges from 0.89 to 336 ng/ml and the area under the plasma concentration-time curve from zero to infinity (AUCo-co) ranges from 13.8 to 957 ng.h/ml. Palonosetron has a volume of distribution of approximately 6.9-7.9 L/kg, with approximately 62% bound to plasma proteins. Approximately 50% of Palonosetron is metabolized into two inactive metabolites that exhibit <1% of the 5-HT3 receptor antagonist activity. Approximately 40% of the drug is metabolised via kidney, 50% by liver CYP2D6 (mainly), CYP3A4 and CYP1A2 isoenzymes. About 50% of the drug goes under metabolism. After a single intravenous dose, approximately 40% is excreted as unchanged drug in the urine after 144 hours. Total body clearance of Palonosetron is 160±35 ml/h/kg, and renal clearance is 66.5±18.2 ml/h/kg in healthy subjects. Palonosetron exhibits a longer half-life (40 hours) and has a greater 5-HT3 receptor binding affinity.
মাত্রা ও সেবনবিধি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Usual dosage: Adult tablet dosage: 0.5 mg daily. Adult IV dosage: A single IV dose of 0.075 mg should be administered over 10 seconds.Chemotherapy-induced nausea and vomiting: Adult tablet dosage: 0.5 mg administered approximately 1 hour prior to the start of chemotherapy. Adult IV dosage: A single IV dose of 0.25 mg should be administered over 30 seconds approximately 30 minutes before the start of chemotherapy.
Radiotherapy-induced nausea and vomiting: A single IV dose of 0.25 mg should be administered over 30 seconds approximately 30 minutes before each week of radiation fraction.
Post-operative nausea and vomiting: A single IV dose of 0.075 mg should be administered over 10 seconds immediately before induction of anesthesia.
Children dosage: (1 month to 17 years): A single IV dose at 20 mcg/kg body weight. Which maximum dose is 1.5 mg.
ঔষধের মিথষ্ক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
In controlled clinical trials, Palonosetron injection has been safely administered with corticosteroids, analgesics, antiemetics/antinauseants, antispasmodics and anticholinergic agents. Palonosetron did not inhibit the antitumor activity of cisplatin, cyclophosphamide, cytarabine, doxorubicin and mitomycin C in murine tumor models. Concomitant administration of Palonosetron and metoclopramide has no significant pharmacokinetic interactions. In vitro studies indicated that palonosetron is not inhibitor of CYP1A2, CYP2A6, CYP2B6, CYP2C9, CYP2D6, CYP2E1 & CYP3A4/5 (CYP2C19 was not investigated) nor does it induce the activity of CYP1A2, CYP2D6 or CYP3A4/5. Therefore, the potential for clinically significant drug interactions with Palonosetron appears to be low.প্রতিনির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Palonosetron is contraindicated in patients known to have hypersensitivity to the drug or any of its components.পার্শ্ব প্রতিক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
The most common adverse reactions are headaches and constipation.গর্ভাবস্থায় ও স্তন্যদানকালে
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregnancy category 'B'. It is not known whether Palonosetron is excreted in breast milk.মাত্রাধিক্যতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
There is no known antidote to Palonosetron. Overdose should be managed with supportive care.সংরক্ষণ
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Store in a cool & dry place, protected from light.বিকল্প ব্র্যান্ড: Palonosetron
একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।